Jeremy Grantham's MD Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 9,692 shares of Pediatrix Medical Group, Inc. (MD) worth $207,312, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in MD, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2014, adding 57,895 shares. Largest reduction occurred in Q2 2016, reducing 71,400 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Pediatrix Medical Group (MD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pediatrix Medical Group (MD) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +9,692 | New Buy | 9,692 | $21.39 |
| Q3 2023 | -47,416 | Sold Out | 0 | $0.00 |
| Q2 2023 | +25,716 | Add 118.51% | 47,416 | $14.21 |
| Q1 2023 | -2,200 | Reduce 9.21% | 21,700 | $14.91 |
| Q4 2022 | +1,100 | Add 4.82% | 23,900 | $14.86 |
| Q3 2022 | +22,800 | New Buy | 22,800 | $16.49 |
| Q1 2021 | -37,500 | Sold Out | 0 | $0.00 |
| Q4 2020 | +37,500 | New Buy | 37,500 | $24.53 |
| Q2 2016 | -71,400 | Sold Out | 0 | $0.00 |
| Q1 2016 | -300 | Reduce 0.42% | 71,400 | $64.62 |
| Q4 2015 | +25,400 | Add 54.86% | 71,700 | $71.66 |
| Q3 2015 | -700 | Reduce 1.49% | 46,300 | $76.78 |
| Q2 2015 | -19,100 | Reduce 28.90% | 47,000 | $74.11 |
| Q1 2015 | -21,700 | Reduce 24.72% | 66,100 | $72.51 |
| Q4 2014 | -24,401 | Reduce 21.75% | 87,800 | $66.10 |
| Q3 2014 | -27,900 | Reduce 19.91% | 112,201 | $54.82 |
| Q2 2014 | -16,800 | Reduce 10.71% | 140,101 | $58.15 |
| Q1 2014 | +57,895 | Add 58.48% | 156,901 | $61.98 |
| Q4 2013 | -7,994 | Reduce 7.47% | 99,006 | $53.38 |
| Q3 2013 | -8,400 | Reduce 7.28% | 107,000 | $50.20 |
| Q2 2013 | +115,400 | Add 0.00% | 115,400 | $45.79 |
Jeremy Grantham's Pediatrix Medical Group Investment FAQs
Jeremy Grantham first purchased Pediatrix Medical Group, Inc. (MD) in Q2 2013, acquiring 115,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Pediatrix Medical Group, Inc. (MD) for 21 quarters since Q2 2013.
Jeremy Grantham's largest addition to Pediatrix Medical Group, Inc. (MD) was in Q2 2013, adding 115,400 shares worth $5.28 M.
According to the latest 13F filing for Q1 2026, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 9,692 shares of Pediatrix Medical Group, Inc. (MD), valued at approximately $207,312.
As of the Q1 2026 filing, Pediatrix Medical Group, Inc. (MD) represents approximately 0.00% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Pediatrix Medical Group, Inc. (MD) was 156,901 shares, as reported at the end of Q1 2014.